¼¼°èÀÇ ¾à¹°°¨½Ã(PV) ½ÃÀå : ½ÃÀå ºÐ¼®°ú ¿¹Ãø(-2033³â) - À¯Çüº°, Á¦Ç°º°, ¼­ºñ½ºº°, ±â¼úº°, ÄÄÆ÷³ÍÆ®º°, ¿ëµµº°, ÃÖÁ¾ »ç¿ëÀÚº°, ¸ðµâº°, ±â´Éº°, Àü°³º°, Áö¿ªº°
Pharmacovigilance (PV) Market Analysis and Forecast to 2033: Type, Product, Services, Technology, Component, Application, End User, Module, Functionality, Deployment
»óǰÄÚµå : 1598954
¸®¼­Ä¡»ç : Global Insight Services LLC
¹ßÇàÀÏ : 2024³â 07¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 387 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,750 £Ü 6,685,000
Single User License help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy & Paste °¡´ÉÇϸç, Àμâ´Â °¡´ÉÇÕ´Ï´Ù.
US $ 5,750 £Ü 8,093,000
Site License help
PDF, Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷(±¹°¡)ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy & Paste °¡´ÉÇÕ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,750 £Ü 9,500,000
Enterprise License help
PDF, Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ Àü ¼¼°è ¸ðµçºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy & Paste °¡´ÉÇÕ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¼¼°è ¾à¹°°¨½Ã ½ÃÀå ±Ô¸ð´Â 2023³â 89¾ï ´Þ·¯¿¡¼­ 2033³â 225¾ï ´Þ·¯·Î È®´ëµÇ¸ç, CAGRÀº ¾à 10.0%°¡ µÉ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¾à¹°°¨½Ã(PV) ½ÃÀåÀº ÀǾàǰÀÇ ºÎÀÛ¿ëÀ» ¸ð´ÏÅ͸µ, °ËÃâ, Æò°¡ ¹× ¿¹¹æÇÏ´Â °ÍÀ» Æ÷ÇÔÇÕ´Ï´Ù. ¸®½ºÅ© °ü¸®, ±ÔÁ¦ Áؼö µîÀÇ È°µ¿ Æ÷ÇÔ ÀÌ ºÐ¾ß¿¡´Â ¼ÒÇÁÆ®¿þ¾î ¼Ö·ç¼Ç, ÄÁ¼³ÆÃ ¼­ºñ½º, ¾Æ¿ô¼Ò½ÌÀÌ Æ÷ÇԵǾî ÀÖÀ¸¸ç, ¾ö°ÝÇÑ ±ÔÁ¦¿Í ȯÀÚÀÇ ¾ÈÀü¼º¿¡ ´ëÇÑ ¿ä±¸°¡ ³ô¾ÆÁö¸é¼­ ±â¼ú Çõ½Å°ú ¼ºÀåÀÇ Å« ±âȸ¸¦ °¡Á®¿À°í ÀÖ½À´Ï´Ù.

¾à¹°°¨½Ã(PV) ½ÃÀåÀº ÀǾàǰÀÇ ¾ÈÀü¼º°ú ±ÔÁ¦ ÁؼöÀÇ Á߿伺 Áõ°¡¿¡ ¿µÇâÀ» ¹ÞÀ¸¸ç »ó´çÇÑ ¼ºÀåÀ» ÀÌ·ç°í ÀÖ½À´Ï´Ù. ¼ÒÇÁÆ®¿þ¾î ¼Ö·ç¼Ç ºÎ¹®ÀÌ ½ÃÀåÀ» ¸®µåÇϰí ÀÖ½À´Ï´Ù. Á¦¾à ±â¾÷ÀÌ ºñ¿ë È¿À²¼º°ú PVÀÇ È¿À²ÀûÀÎ ¿î¿µÀ» ¿ä±¸Çϰí Àֱ⠶§¹®¿¡ ¼­ºñ½º, ƯÈ÷ ¾Æ¿ô¼Ò½Ì ¼öŹÀÌ µÎ ¹øÂ°·Î ³ôÀº ½ÇÀûÀ» ¿Ã¸®°í ÀÖ½À´Ï´Ù. Á¦¾à ¾÷°è¿¡ ÃßÁø µÈ ºÏ¹Ì°¡ ¿ìÀ§ ±ÔÁ¦ »óȲÀÌ Á¤ºñµÇ¾î PV½Ç¹«ÀÇ µµÀÔÀÌ ÁøÇàµÇ°í ÀÖ´Â À¯·´ÀÌ ÀÌ¿¡ °è¼ÓµÇ°í ÀÖ½À´Ï´Ù. µ¶ÀÏÀÌ ÁÖ¿ä °øÇå±¹ÀÔ´Ï´Ù. ¾Æ½Ã¾ÆÅÂÆò¾çÀº ÀÓ»ó½ÃÇè Áõ°¡, ÇコÄɾî ÅõÀÚ Áõ°¡, ƯÈ÷ Àεµ³ª Áß±¹ µî¿¡¼­ÀÇ ±ÔÁ¦±âÁØÀÇ ÁøÈ­¿¡ ÈûÀÔ¾î ±Þ¼ºÀåÀ» ÀÌ·ç·Á°í Çϰí ÀÖ½À´Ï´Ù. PV°¡ ÇÏ´Â Áß¿äÇÑ ¿ªÇÒÀ» µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù.

º» º¸°í¼­¿¡¼­´Â ¼¼°èÀÇ ¾à¹°°¨½Ã(PV) ½ÃÀå¿¡ ´ëÇØ Á¶»çÇßÀ¸¸ç,, ½ÃÀå °³¿ä¿Í ÇÔ²² À¯Çüº°, Á¦Ç°º°, ¼­ºñ½ºº°, ±â¼úº°, ÄÄÆ÷³ÍÆ®º°, ¿ëµµº°, ÃÖÁ¾ »ç¿ëÀÚº°, ¸ðµâº°, ±â´Éº°, Àü°³º°, Áö¿ªº° µ¿Çâ, ½ÃÀå ÁøÃâ±â¾÷ ÇÁ·ÎÆÄÀÏ µîÀ» Á¤¸®Çß½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¾à¹°°¨½Ã(PV) ½ÃÀå °³¿ä

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå¿¡ °üÇÑ Áß¿ä ÀλçÀÌÆ®

Á¦4Àå ¾à¹°°¨½Ã(PV) ½ÃÀå Àü¸Á

Á¦5Àå ¾à¹°°¨½Ã(PV) ½ÃÀå Àü·«

Á¦6Àå ¾à¹°°¨½Ã(PV) ½ÃÀå ±Ô¸ð

Á¦7Àå ¾à¹°°¨½Ã(PV) ½ÃÀå, À¯Çüº°

Á¦8Àå ¾à¹°°¨½Ã(PV) ½ÃÀå, Á¦Ç°º°

Á¦9Àå ¾à¹°°¨½Ã(PV) ½ÃÀå, ¼­ºñ½ºº°

Á¦10Àå ¾à¹°°¨½Ã(PV) ½ÃÀå, ±â¼úº°

Á¦11Àå ¾à¹°°¨½Ã(PV) ½ÃÀå, ÄÄÆ÷³ÍÆ®º°

Á¦12Àå ¾à¹°°¨½Ã(PV) ½ÃÀå, ¿ëµµº°

Á¦13Àå ¾à¹°°¨½Ã(PV) ½ÃÀå, ÃÖÁ¾ »ç¿ëÀÚº°

Á¦14Àå ¾à¹°°¨½Ã(PV) ½ÃÀå, ¸ðµâº°

Á¦15Àå ¾à¹°°¨½Ã(PV) ½ÃÀå, ±â´Éº°

Á¦16Àå ¾à¹°°¨½Ã(PV) ½ÃÀå, Àü°³º°

Á¦17Àå ¾à¹°°¨½Ã(PV) ½ÃÀå, Áö¿ªº°

Á¦18Àå °æÀï ±¸µµ

Á¦19Àå ±â¾÷ ÇÁ·ÎÆÄÀÏ

JHS
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The global pharmacovigilance market is anticipated to expand from $8.9 billion in 2023 to $22.5 billion by 2033, with a CAGR of approximately 10.0%.

The Pharmacovigilance (PV) Market encompasses the surveillance, detection, assessment, and prevention of adverse effects of pharmaceutical products. This sector is pivotal in ensuring drug safety and efficacy, involving activities such as data collection, risk management, and regulatory compliance. It includes software solutions, consulting services, and outsourcing, driven by stringent regulations and the growing need for patient safety, thereby presenting significant opportunities for innovation and growth.

The Pharmacovigilance (PV) market is witnessing substantial growth, influenced by the increasing emphasis on drug safety and regulatory compliance. The software solutions segment leads the market, driven by the demand for advanced data analytics and automation in safety reporting. Services, particularly contract outsourcing, emerge as the second-highest performing sub-segment, as pharmaceutical companies seek cost-effective and efficient PV operations. Regionally, North America dominates, propelled by stringent regulatory frameworks and a robust pharmaceutical industry. Europe follows closely, with its well-established regulatory landscape and high adoption of PV practices. Within Europe, the United Kingdom and Germany are key contributors, benefiting from strong healthcare infrastructure and innovation in drug safety technologies. The Asia-Pacific region is poised for rapid growth, supported by increasing clinical trials, rising healthcare investments, and evolving regulatory standards, particularly in countries like India and China. These dynamics underscore the critical role of PV in safeguarding public health and ensuring pharmaceutical integrity.

Key Companies

Accenture, IQVIA, Cognizant, Parexel, ICON, PRA Health Sciences, Syneos Health, PAREXEL International, Medpace, Pharm- Olam, Worldwide Clinical Trials, Wuxi Clinical, FMD K& L, Genpact, Linical, Bio Clinica, Chiltern, CRF Health, TFS International, Premier Research, Pharma Safe, Vigilant Rx, Safety Med Solutions, Med Guard Analytics, Pharma Watch, Safe Pharma Insights, Med Alert Global, Pharma Shield, Secure Rx Monitoring, Vigilance Pro, Safe Guard Pharma, Pharma Sentinel, Med Secure Insights, Vigil Rx Solutions, Pharma Care Analytics, Safety Net Pharma, Med Vigil Insights, Pharma Protect, Vigilance Guard, Med Safe Solutions

Research Scope

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1. Pharmacovigilance (PV) Market Overview

2. Executive Summary

3. Premium Insights on the Market

4. Pharmacovigilance (PV) Market Outlook

5. Pharmacovigilance (PV) Market Strategy

6. Pharmacovigilance (PV) Market Size

7. Pharmacovigilance (PV) Market, by Type

8. Pharmacovigilance (PV) Market, by Product

9. Pharmacovigilance (PV) Market, by Services

10. Pharmacovigilance (PV) Market, by Technology

11. Pharmacovigilance (PV) Market, by Component

12. Pharmacovigilance (PV) Market, by Application

13. Pharmacovigilance (PV) Market, by End User

14. Pharmacovigilance (PV) Market, by Module

15. Pharmacovigilance (PV) Market, by Functionality

16. Pharmacovigilance (PV) Market, by Deployment

17. Pharmacovigilance (PV) Market, by Region

18. Competitive Landscape

19. Company Profiles

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â